SOPHiA GENETICS
PublicSOPHiA GENETICS is now publicly traded
The data on this page reflects SOPHiA GENETICS's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 28, 2021
Last Round
Follow-on Offering
Jun 16, 2026
Total Funding Raised
$610.05M
Company Overview
SOPHiA GENETICS is a healthcare technology company that provides a cloud-native SaaS platform, SOPHiA DDM™, which utilizes AI and machine learning to analyze complex multimodal data sets to generate actionable insights for healthcare providers, laboratories, and biopharmaceutical institutions.
Sector
Healthcare
AI Layer
Application
Keywords
SOPHiA GENETICS Comparables
Compare SOPHiA GENETICS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeqOne | 79% | |
| Caris Life Sciences | 76% | |
| Geneyx | 75% |
For institutional investors. Book with your work email.
SOPHiA GENETICS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jun 16, 2026 | ||||
| Debt | May 2, 2024 | ||||
| Private Placement | Jul 28, 2021 | ||||
| IPO | Jul 28, 2021 | ||||
| Series F | Oct 1, 2020 | ||||
Series E | Jan 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SOPHiA GENETICS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 360 Capital | Series D |
| Pictet Group | Series F |
| Idinvest Partners | Series E |
| Perceptive Advisors | Debt |
| Swisscom Ventures | Series F |
| HV Fund | Series F |
| 360 Capital | Series D |
For institutional investors. Book with your work email.
SOPHiA GENETICS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.